| Filed On | Filing |
|---|---|
| 20 Oct 2026 |
Form 3: Faucetta Stephen Edward Joseph Okzynski, Director
No securities owned |
| 20 Oct 2026 |
Form 3: Khorassani Mohsen, Director
No securities owned |
| 15 Oct 2026 |
Form 3: Balatsos Phillip, Director
No securities owned |
| 15 Oct 2026 | 6-K |
| 13 Oct 2026 |
Form 3: Hancox Andrew, Director
No securities owned |
| 07 Oct 2026 | 6-K |
| 17 Sep 2026 | 6-K |
| 09 Sep 2026 | SCHEDULE 13D |
| 11 Aug 2026 | 6-K |
| 10 Aug 2026 | SCHEDULE 13D/A |
| 29 Jul 2026 | SCHEDULE 13G/A |
| 29 Apr 2026 | 6-K |
| 29 Apr 2026 | 20-F |
| 22 Apr 2026 | SCHEDULE 13G |
| 17 Apr 2026 |
Form 4: Deng Conglin, Director
Received 40,000 shares by exercise or conversion |
| 31 Mar 2026 |
Form 3: Choong Khuat Leok, Director
Holds 2,400 shares of Ordinary Shares |
| 31 Mar 2026 |
Form 3: Zhang Kai, Chief Financial Officer
No securities owned |
| 31 Mar 2026 |
Form 3: Zhan Chuan, Director
No securities owned |
| 31 Mar 2026 |
Form 3: Sun Yanyan, Director
No securities owned |
| 26 Feb 2026 | 6-K |
Loading...
